Cannabis Research
Cannabis and Heart Health: Understanding the Cardiovascular Risks
As cannabis legalization spreads across the globe and public acceptance of its use continues to rise, a new set of public health concerns is coming into focus—chief among them is the potential impact on cardiovascular health. While cannabis is often touted for its therapeutic properties and social benefits, which it does indeed offer, emerging research is shedding light on a more sobering aspect of its use: an increased risk of heart-related conditions among regular users.
A Surge in Use and Shifting Perceptions
Over the past decade, cannabis has undergone a dramatic transformation in the eyes of the public and policymakers alike. What was once a stigmatized substance is now legally accessible in many jurisdictions for both medical and recreational purposes. This shift has contributed to a sharp rise in regular cannabis use, particularly among young adults and older populations seeking alternatives to conventional pharmaceuticals. Surprisingly, an increase in usage has not been seen among adolescents to date.
As mentioned, although cannabis offers numerous potential benefits—such as pain relief, reduced anxiety, appetite stimulation, and anti-inflammatory effects—new research suggests that regular consumption may come at a cardiovascular cost.
Mounting Evidence of Cardiovascular Harm
Recent scientific findings underscore a growing concern in the medical community. A January 2025 study1 published in Nature Reviews Cardiology draws attention to the biological mechanisms by which cannabis can negatively impact cardiovascular health. The review concludes that cannabis use activates the endocannabinoid system in ways that increase heart rate, blood pressure variability, and vascular inflammation. These physiological changes may raise the likelihood of arrhythmias, myocardial infarction, and stroke—especially in individuals with existing cardiovascular conditions or risk factors.
Meanwhile, the American College of Cardiology (ACC) has released multiple statements supporting this emerging consensus. In a 2023 press release, the ACC shared results from a study2 showing that frequent cannabis use is linked to a higher risk of coronary artery disease (CAD). The research, which examined over 175,000 individuals, found that daily users had approximately a 34% greater chance of developing CAD compared to non-users. These findings held even after controlling for other factors like tobacco use and socioeconomic status.
More recently, in a 2025 press release, the ACC revealed data3 showing that cannabis users face a substantially higher risk of heart attack and stroke, regardless of how the drug is consumed. Individuals using cannabis through smoking, vaping, or edibles were found to be at elevated risk. Notably, the risk extended beyond acute intoxication periods, indicating that long-term use may have persistent physiological effects on the cardiovascular system.
Mechanisms of Risk
As it stands, the cardiovascular implications of cannabis are thought to stem from a combination of direct and indirect effects:
- Sympathomimetic Response: THC, the primary psychoactive compound in cannabis, activates sympathetic nervous system responses, leading to increased heart rate and blood pressure.
- Inflammation and Endothelial Dysfunction: Chronic cannabis use may induce inflammation and impair the endothelial cells that line blood vessels, contributing to arterial stiffness and atherosclerosis.
- Arrhythmias and Oxygen Imbalance: Cannabis can disrupt normal heart rhythms and reduce oxygen delivery to the heart muscle, especially when combined with other substances like tobacco.
These physiological responses are particularly dangerous in older adults, individuals with pre-existing heart disease, and those with comorbidities such as diabetes or obesity.
Balancing the Narrative: Recognizing Cannabis’ Benefits
Despite the emerging concerns, cannabis remains a valuable therapeutic tool for many individuals. It has demonstrated efficacy in managing chronic pain, especially neuropathic pain, which is often resistant to opioids. Cannabis is also used to alleviate nausea in chemotherapy patients, reduce muscle spasticity in multiple sclerosis, and assist with appetite stimulation in those suffering from wasting diseases like HIV/AIDS.
Moreover, the plant’s non-intoxicating compounds—such as cannabidiol (CBD)—are being explored for their anti-inflammatory, neuroprotective, and anxiolytic properties, potentially offering relief without the psychoactive side effects of THC.
For some patients, cannabis represents a safer alternative to addictive prescription medications like opioids or benzodiazepines. Its legal status in many areas has also brought economic and social benefits, including job creation, tax revenue, and reduced criminalization.
Moving Forward: A Call for Education and Caution
As cannabis becomes increasingly normalized, it is essential for both users and healthcare professionals to adopt a more nuanced understanding of its health implications. While cannabis offers genuine benefits, especially in medical contexts, the potential cardiovascular risks associated with regular use should not be overlooked.
The path forward requires balance: embracing cannabis for its benefits while remaining vigilant about its risks. As with any substance that affects human physiology, informed use is the key to maximizing advantages while minimizing harm.
Studies Referenced:
1. Chandy, M., Jimenez-Tellez, N. & Wu, J.C. The relationship between cannabis and cardiovascular disease: clearing the haze. Nat Rev Cardiol (2025). https://doi.org/10.1038/s41569-025-01121-6
2. American College of Cardiology. (2023, February 23). Frequent marijuana use linked to heart disease. https://www.acc.org/About-ACC/Press-Releases/2023/02/23/18/53/Frequent-Marijuana-Use-Linked-to-Heart-Disease
3. American College of Cardiology. (2025, March 17). Cannabis users face substantially higher risk of heart attack and stroke. https://www.acc.org/About-ACC/Press-Releases/2025/03/17/15/35/Cannabis-Users-Face-Substantially-Higher-Risk










